← Browse by Condition
Medical Condition

antiphospholipid syndrome aps

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for antiphospholipid syndrome aps sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1
2
Phase 2
1
Top Sponsors
China Immunotech (Beijing) Biotechnology Co., Ltd. 2 trials
Ruijin Hospital 1 trial
NCT06747312 Phase 2
Recruiting

Effect of Belimumab on Antibody Titers in Primary APS Patients

Enrollment
20 pts
Location
China
Sponsor
Ruijin Hospital
View Trial →
NCT06978647 Phase 1
Recruiting

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Enrollment
12 pts
Location
China
Sponsor
China Immunotech (Beijing) Bio...
View Trial →
NCT07104721 Phase 1
Recruiting

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Enrollment
18 pts
Location
China
Sponsor
China Immunotech (Beijing) Bio...
View Trial →